febuxostat [Ligand Id: 6817] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1164729 (Adenuric, Febuxostat, NSC-758874, TMX-67, Uloric)
There should be some charts here, you may need to enable JavaScript!
  • xanthine dehydrogenase/Xanthine dehydrogenase in Human [ChEMBL: CHEMBL1929] [GtoPdb: 2646] [UniProtKB: P47989]
  • Xanthine dehydrogenase in Bovine [ChEMBL: CHEMBL3649] [UniProtKB: P80457]
There should be some charts here, you may need to enable JavaScript!
  • xanthine dehydrogenase in Human [GtoPdb: 2646] [UniProtKB: P47989]
  • xanthine dehydrogenase in Bovine [GtoPdb: 2646]
  • xanthine dehydrogenase/Xanthine dehydrogenase/oxidase in Rat [ChEMBL: CHEMBL1075246] [GtoPdb: 2646] [UniProtKB: P22985]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Flavin reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5019] [UniProtKB: P30043]
ChEMBL Binding affinity to human N-terminal His6-tagged and thrombin cleavage fused BLVRB expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry B 5.79 pKd 1630 nM Kd J Med Chem (2022) 65: 2548-2557 [PMID:34957824]
ChEMBL Binding affinity to human N-terminal His6-tagged and thrombin cleavage fused BLVRB expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry B 5.79 pKd 1621.81 nM Kd J Med Chem (2022) 65: 2548-2557 [PMID:34957824]
xanthine dehydrogenase/Xanthine dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1929] [GtoPdb: 2646] [UniProtKB: P47989]
ChEMBL Inhibition of xanthine dehydrogenase (unknown origin) B 8.51 pKi 3.1 nM Ki Eur J Med Chem (2019) 166: 186-196 [PMID:30769179]
ChEMBL Inhibition of xanthine oxidase (unknown origin) B 9.22 pKi 0.6 nM Ki Eur J Med Chem (2019) 166: 186-196 [PMID:30769179]
ChEMBL Non-competitive inhibition of human xanthine oxidase B 10 pKi 0.1 nM Ki Eur J Med Chem (2017) 135: 491-516 [PMID:28478180]
ChEMBL Inhibition of xanthine oxidase using xanthine as substrate at 30 mins by spectrophotometric analysis B 7.52 pIC50 30 nM IC50 Bioorg Med Chem Lett (2012) 22: 7543-7546 [PMID:23122864]
ChEMBL Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate preincubated for 5 mins followed by substrate addition measured for 20 mins by spectrophotometric method B 7.89 pIC50 13 nM IC50 Eur J Med Chem (2018) 155: 590-595 [PMID:29920453]
ChEMBL Inhibition of C-terminally FLAG-tagged human xanthine oxidase (amino acid 1 to 1333) expressed in baculovirus system after 15 mins by spectrophotometry B 8.9 pIC50 1.26 nM IC50 Bioorg Med Chem Lett (2014) 24: 1315-1321 [PMID:24508129]
GtoPdb Inhibition of baculovirus expressed C-terminally FLAG-tagged human xanthine oxidase (aa 1-1333). - 8.9 pIC50 1.26 nM IC50 Bioorg Med Chem Lett (2014) 24: 1315-21 [PMID:24508129]
Xanthine dehydrogenase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3649] [UniProtKB: P80457]
ChEMBL Mixed-type inhibition of bovine xanthine oxidase assessed as enzyme-inhibitor complex B 9.05 pKi 0.9 nM Ki J Nat Prod (2014) 77: 1693-1699 [PMID:25060641]
ChEMBL Mixed-type inhibition of bovine xanthine oxidase B 9.92 pKi 0.12 nM Ki J Nat Prod (2014) 77: 1693-1699 [PMID:25060641]
ChEMBL Inhibition of bovine milk xanthine oxidase using xanthine as substrate preincubated for 5 mins followed by substrate addition by UV-visible spectrophotometry B 7.52 pIC50 30 nM IC50 Medchemcomm (2019) 10: 128-147 [PMID:30931089]
ChEMBL Inhibition of bovine milk xanthine oxidase using xanthine as substrate assessed as decrease in uric acid formation preincubated for 5 mins B 7.6 pIC50 25 nM IC50 Bioorg Med Chem Lett (2014) 24: 495-500 [PMID:24388807]
ChEMBL Inhibition of bovine milk xanthine oxidase using xanthine as substrate incubated for 15 mins followed by substrate addition and measured at 30 sec interval for 2 mins by spectrophotometrically B 7.63 pIC50 23.6 nM IC50 Eur J Med Chem (2019) 181: 111559-111559 [PMID:31376568]
ChEMBL Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated with enzyme for 15 mins followed by substrate addition and measured every 30 secs for 2 mins by spectrophotometric method B 7.63 pIC50 23.6 nM IC50 Eur J Med Chem (2019) 181: 111558-111558 [PMID:31369933]
ChEMBL Inhibition of bovine xanthine oxidase-mediated uric acid production after 30 mins by spectrophotometric analysis B 7.7 pIC50 20 nM IC50 Bioorg Med Chem Lett (2013) 23: 834-838 [PMID:23265878]
ChEMBL Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 15 mins followed by substrate addition measured at 30 sec interval for upto 2 mins by spectrophotometric analysis B 7.72 pIC50 18.9 nM IC50 J Med Chem (2020) 63: 15752-15772 [PMID:33307675]
ChEMBL Inhibition of bovine xanthine oxidase assessed as inhibition of uric acid formation after 30 mins by spectrophotometry B 7.73 pIC50 18.6 nM IC50 Eur J Med Chem (2014) 85: 508-516 [PMID:25113879]
ChEMBL Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 15 mins followed by substrate addition measured for every 30 sec by spectrophotometric analysis B 7.74 pIC50 18 nM IC50 Bioorg Med Chem (2021) 38: 116117-116117 [PMID:33838610]
ChEMBL Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation preincubated for 5 mins followed by xanthine addition and measured after 20 mins by spectrophotometry B 7.74 pIC50 18 nM IC50 Bioorg Med Chem (2019) 27: 1818-1823 [PMID:30885567]
ChEMBL Inhibition of bovine milk xanthine-oxidase using xanthine as substrate after 5 mins by spectrophotometric method B 8 pIC50 10 nM IC50 Bioorg Med Chem (2017) 25: 3606-3613 [PMID:28545814]
ChEMBL Inhibition of bovine XO using xanthine as substrate after 120 mins by spectrophotometric analysis B 8 pIC50 10 nM IC50 Eur J Med Chem (2015) 103: 343-353 [PMID:26363870]
ChEMBL Inhibition of bovine XO using xanthine as substrate after 120 mins by spectrophotometric analysis B 8 pIC50 10 nM IC50 Eur J Med Chem (2015) 103: 343-353 [PMID:26363870]
ChEMBL Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate incubated for 3 mins by microplate assay B 8.15 pIC50 7 nM IC50 Eur J Med Chem (2020) 186: 111883-111883 [PMID:31761385]
ChEMBL Inhibition of bovine milk xanthine oxidoreductase pre-incubated for 3 mins followed xanthine substrate addition and measured every 1 mins for 10 mins by spectrophotometry B 8.28 pIC50 5.2 nM IC50 Eur J Med Chem (2017) 140: 20-30 [PMID:28918097]
ChEMBL Inhibition of bovine milk xanthine oxidase using xanthine as substrate preincubated for 3 mins followed by substrate addition and measured at 1 min for 10 mins B 8.32 pIC50 4.8 nM IC50 Bioorg Med Chem Lett (2019) 29: 525-528 [PMID:30630716]
ChEMBL Inhibition of bovine xanthine oxidase by spectrophotometry B 8.52 pIC50 3 nM IC50 Eur J Med Chem (2010) 45: 2663-2670 [PMID:20189693]
xanthine dehydrogenase in Human [GtoPdb: 2646] [UniProtKB: P47989]
GtoPdb Inhibition of baculovirus expressed C-terminally FLAG-tagged human xanthine oxidase (aa 1-1333). - 8.9 pIC50 1.26 nM IC50 Bioorg Med Chem Lett (2014) 24: 1315-21 [PMID:24508129]
xanthine dehydrogenase in Bovine [GtoPdb: 2646]
GtoPdb In vitro assay using purified bovine enzyme - 9.92 pKi 0.12 nM Ki J Biol Chem (2003) 278: 1848-55 [PMID:12421831]
GtoPdb In vitro assay using purified bovine enzyme - 7.52 pIC50 30 nM IC50 Bioorg Med Chem Lett (2012) 22: 7543-6 [PMID:23122864]
xanthine dehydrogenase/Xanthine dehydrogenase/oxidase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075246] [GtoPdb: 2646] [UniProtKB: P22985]
ChEMBL Inhibition of rat xanthine oxidase B 8.4 pIC50 3.98 nM IC50 Bioorg Med Chem Lett (2014) 24: 1315-1321 [PMID:24508129]

ChEMBL data shown on this page come from version 33:

Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]